Psychiatry Research: Neuroimaging
Volume 172, Issue 3 , Pages 205-209 , 30 June 2009

Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: A proton magnetic resonance spectroscopy study

  • Rhandi Senaratne

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, Faculty of Health Sciences, McMaster University, F130-301 James Street South, Hamilton, Ontario, Canada L8P 3B6
    • ,
  • Andrea M. Milne

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, Faculty of Health Sciences, McMaster University, F130-301 James Street South, Hamilton, Ontario, Canada L8P 3B6
    • ,
  • Glenda M. MacQueen

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, Faculty of Health Sciences, McMaster University, F130-301 James Street South, Hamilton, Ontario, Canada L8P 3B6
    • Brain Body Institute, St. Joseph's Healthcare, Hamilton, Ontario, Canada
    • ,
  • Geoffrey B.C. Hall

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, Faculty of Health Sciences, McMaster University, F130-301 James Street South, Hamilton, Ontario, Canada L8P 3B6
    • Brain Body Institute, St. Joseph's Healthcare, Hamilton, Ontario, Canada
    • Corresponding Author InformationCorresponding author. Department of Psychiatry and Behavioural Neurosciences, Faculty of Health Sciences, McMaster University, F130-301 James Street South, Hamilton, Ontario, Canada L8P 3B6. Tel.: +1 905 522 1155x34942.

Received 3 December 2007 ,Revised 30 May 2008 ,Accepted 4 July 2008.

References 

  1. Altshuler LL, Bookheimer SY, Townsend J, Proenza MA, Eisenberger N, Sabb F, et al. Blunted activation in orbitofrontal cortex during mania: a functional magnetic resonance imaging study. Biological Psychiatry. 2005;58:763–769
  2. Amaral JAMS, Lafer B, Tamada RS, Issler CK, Cerri GG, de Castro CC. A HMRS study of the anterior cingulate gyrus in euthymic bipolar patients taking lithium. Biological Psychiatry. 2002;51S:87
  3. Anderson SW, Bechara A, Damasio H, Tranel D, Damasio AR. Impairment of social and moral behavior related to early damage in human prefrontal cortex. Nature Neuroscience. 1999;2:1032–1037
  4. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biological Psychiatry. 1998;44:88–97
  5. Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biological Psychiatry. 2003;53:906–913
  6. Blumberg H, Kaufman J, Martin A, Whiteman R, Zhang J, Gore J, et al. Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. Archives of General Psychiatry. 2003;60:1201–1208
  7. Brambilla P, Stanley JA, Nicoletti MA, Sassi RB, Mallinger AG, Frank E, et al. H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. Journal of Affective Disorders. 2005;86:61–67
  8. Bruhn H, Stoppe G, Staedt J, Merboldt KD, Hanicke W, Frahm J. Quantitative proton MRS in vivo shows cerebral myo-inositol and cholines to be unchanged in manic-depressive patients treated with lithium. In: Proceedings of the International Society for Magnetic Resonance in Medicine. 1993;p. 1543
  9. Castillo M, Kwock L, Courvoisie H, Hooper SR. Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. AJNR. American Journal of Neuroradiology. 2000;21:832–838
  10. Cecil KM, Del Bello MP, Morey R, Strakowski SM. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disorders. 2002;4:357–365
  11. Chen G, Zeng WZ, Jiang L, Yuang PX, Zhao J, Manji HK. The mood stabilizing agents lithium and valproate robustly increase the expression of the neuroprotective protein bcl-2 in the CNS. Journal of Neurochemistry. 1999;72:879–882
  12. Cunningham WA, Johnson MK, Gatenby JC, Gore JC, Banaji MR. Neural components of social evaluation. Journal of Personality and Social Psychology. 2003;85:639–649
  13. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Archives of General Psychiatry. 2004;61:450–458
  14. Dean B, Scarr E, McLeod M. Changes in hippocampal GABAA receptor subunit composition in bipolar 1 disorder. Brain Research: Molecular Brain Research. 2005;138:145–155
  15. Elliot R, Ogilvie A, Rubinsztein J, Calderon G, Dolan R, Sahakian B. Abnormal ventral frontal response during performance of an affective go/no go task in patients with mania. Biological Psychiatry. 2004;55:1163–1170
  16. Frey BN, Folgierini M, Nicoletti M, Machado-Vieria R, Stanley JA, Soares JC, et al. A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania. Human Psychopharmacology. 2005;30:133–139
  17. Frey BN, Andreazza AC, Nery FG, Martins MR, Quevedo J, Soares JC, et al. The role of the hippocampus in the pathophysiology of bipolar disorder. Behavioural Pharmacology. 2007;18:419–430
  18. Friedman SD, Dager SR, Parow A, Hirashima F, Demopulos C, Stoll AL, et al. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biological Psychiatry. 2004;56:340–348
  19. Glitz DA, Manji HK, Moore GJ. Mood disorders: treatment-induced changes in brain neurochemistry and structure. Seminars in Clinical Neuropsychiatry. 2002;7:269–280
  20. Hamakawa H, Kato T, Murashita J, Kato N. Quantitative magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. European Archives of Psychiatry and Clinical Neuroscience. 1998;248:53–58
  21. Hamakawa H, Kato T, Shioiri T, Inubushi T, Kato N. Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychological Medicine. 1999;29:639–644
  22. Harvey I, Persaud R, Ron MA, Baker G, Murray RM. Volumetric MRI measurements in bipolars compared with schizophrenics and healthy controls. Psychological Medicine. 1994;24:689–699
  23. Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Archives of General Psychiatry. 2002;59:521–529
  24. Jenkins BG, Koroshetz WJ, Beal F, Rosen BR. Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology. 1993;43:2689–2695
  25. Kato T, Hamakawa H, Shioiri T, Murashita J, Takahashi Y, Takahashi S, et al. Choline containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. Journal of Psychiatry and Neuroscience. 1996;21:248–254
  26. Lafer B, Renshaw PF, Sachs G, Christensen JD, Yurgelun-Todd D, Stoll AL. Proton MRS of the basal ganglia in bipolar disorder. Biological Psychiatry. 1994;35:685
  27. Liu L, Schulz SC, Lee S, Reutiman TJ, Fatemi SH. Hippocampal CA1 pyramidal cell size is reduced in bipolar disorder. Cellular and Molecular Neurobiology. 2007;27:351–358
  28. Malhi GS, Valenzuela M, Wen W, Sachdev P. Magnetic resonance spectroscopy and its applications in psychiatry. The Australian and New Zealand Journal of Psychiatry. 2002;36:31–43
  29. Manji HK, Moore GJ, Chen G. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. Journal of Clinical Psychiatry. 2000;61:82–96
  30. Meyerhoff DJ, Mackay S, Constans JM, Norman D, Van Dyke C, Fein G, et al. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Annals of Neurology. 1994;36:40–47
  31. Michael N, Erfurth A, Ohrmann P, Gossling M, Arolt V, Heindel W, et al. Acute mania is accompanied by elevated glutamate/glutamine levels the left dorsolateral prefrontal cortex. Psychopharmacology. 2003;168:344–346
  32. Moore GJ, Galloway MP. MRS: neurochemistry and treatment effects in affective disorders. Psychopharmacology Bulletin. 2002;36:5–23
  33. Moore CM, Breeze JL, Gruber SA, Babb SM, Frederick BB, Villafuerte RA, et al. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulated cortex. Bipolar Disorders. 2000;2:207–216
  34. Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB, et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?. Biological Psychiatry. 2000;48:1–8
  35. Ohara K, Isoda H, Suzuki Y, Takehera Y, Ochiai M, Takeda H, et al. Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar 1 affective disorder. Psychiatry Research: Neuroimaging. 1998;84:55–60
  36. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine. 1993;30:672–679
  37. Rolls ET, Hornak J, Wade D, McGrath J. Emotion-related learning in patients with social and emotional changes associated with frontal lobe damage. Journal of Neurology, Neurosurgery, and Psychiatry. 1994;57:1518–1524
  38. Rowe MK, Chuang DM. Lithium neuroprotection: molecular mechanisms and clinical implications. Expert Reviews in Molecular Medicine. 2004;6:1–18
  39. Silverstone PH, Wu RH, O'Donnel T, Ulrich M, Asghar SJ, Hanstock CC. Chronic treatment with both lithium but not sodium valproate increases cortical n-acetyl-aspartate concentrations in euthymic bipolar patients. International Clinical Psychopharmacology. 2003;18:73–79
  40. Stanley JA. In Vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders. Canadian Psychiatric Association Journal. 2002;47:315–326
  41. Stoll AL, Renshaw PF, Sachs GS, Guimaraes AR, Miller C, Cohen BM, et al. The human brain resonance of choline-containing compounds is similar in patients receiving lithium treatment and controls: an in vivo proton magnetic resonance spectroscopy study. Biological Psychiatry. 1992;32:944–949
  42. Videbech P, Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. The American Journal of Psychiatry. 2004;161:1957–1966
  43. Wessa M, Houenou J, Paillere-Martinot M, Berthoz S, Artiges E, Leboyer M, et al. Fronto-striatal overactivation in euthymic bipolar patients during an emotional go/nogo task. The American Journal of Psychiatry. 2007;164:638–646
  44. Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, Spielman D, Ketter TA. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biological Psychiatry. 2000;133:429–435
  45. Yildiz-Yesioglu A, Ankerst DP. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2006;30:969–995
  46. Yucel K, Taylor V, McKinnon MC, MacDonald K, Alda M, Young LT, et al. Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology. 2008;33:361–367

PII: S0925-4927(08)00104-2

doi: 10.1016/j.pscychresns.2008.07.007

Psychiatry Research: Neuroimaging
Volume 172, Issue 3 , Pages 205-209 , 30 June 2009

Article Tools

* Image Usage & Resolution